Gynazol 50mg Capsule contains Danazol, a synthetic steroid derivative used primarily in the management of endometriosis, fibrocystic breast disease, and hereditary angioedema. Danazol exerts its therapeutic effects by suppressing the pituitary-ovarian axis, thereby reducing the production of gonadotropins and subsequently decreasing estrogen levels. This hormonal modulation helps alleviate symptoms associated with estrogen-dependent conditions, such as pelvic pain and breast tenderness. Gynazol is indicated for the treatment of endometriosis to reduce endometrial lesions and associated pain, as well as for fibrocystic breast disease to diminish breast swelling and discomfort. Additionally, it is employed in the prophylaxis of hereditary angioedema attacks by stabilizing vascular permeability. The recommended dosage varies depending on the condition being treated and should be individualized based on patient response and tolerability. Common adverse effects include weight gain, acne, hirsutism, and menstrual irregularities, while more serious but less frequent side effects may involve hepatic dysfunction and thromboembolic events. Due to its androgenic properties, Gynazol is contraindicated in pregnancy and should be used with caution in patients with liver impairment or a history of thromboembolism. Regular monitoring by a healthcare professional is essential to ensure safety and efficacy during treatment.